SPONSOR

University Hospital, Montpellier

Total Trials

Recruiting

Phases

Phase 2

Conditions studied: Metabolic Syndrome Dialysis; Complications Rheumatoid Arthritis (RA)Diffuse Large B Cell Lymphoma Anesthesia Pediatric Surgery Reconstructive Surgery Using Pedicled Perforating or Free Perforating Flaps Pelvic Eschar Traumatic Pathology of the Lower and/or Upper Limb Perioperative

University Hospital, Montpellier is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Metabolic Syndrome, Dialysis; Complications, Rheumatoid Arthritis (RA), Diffuse Large B Cell Lymphoma.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Hospital, Montpellier

How many clinical trials has University Hospital, Montpellier sponsored?

ClinicalMetric currently tracks 17 clinical trials sponsored by University Hospital, Montpellier, of which 17 are actively recruiting participants. These trials cover conditions including Metabolic Syndrome, Dialysis; Complications, Rheumatoid Arthritis (RA). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University Hospital, Montpellier research focus on?

University Hospital, Montpellier clinical trials span Metabolic Syndrome, Dialysis; Complications, Rheumatoid Arthritis (RA), Diffuse Large B Cell Lymphoma, Anesthesia, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University Hospital, Montpellier clinical trial?

To participate in a University Hospital, Montpellier trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Montpellier trials with current recruitment status updated daily.

University Hospital, Montpellier

Frequently Asked Questions — University Hospital, Montpellier

Clinical Trials by University Hospital, Montpellier

Plasma Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in CKD Dialysis Patients

National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?

Intravenous Dexmedetomidine as an Adjuvant to Locoregional Anesthesia in Pediatric Surgery

Study and Modeling of Perforator Flap Vascularization

Pediatric Perioperative Satisfaction Questionnaire

Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)

Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)

Evaluation of Mobility in Subjects With Severe Knee Osteoarthritis Who Are to Undergo Total Knee Replacement

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

Comparative Observational Study of Supra-annular Versus Intra-annular Self-expanding Aortic Valves in Routine Clinical Practice

Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein

Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients

A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis Symptoms

Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis

Analysis of the Prevalence of Sensitization to Plants Containing Gibberellins Using Realistic Skin Prick Tests

Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management